These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1167 related articles for article (PubMed ID: 1686168)

  • 1. Proto-oncogene expression in dermal naevi and melanomas.
    Peris K; Cerroni L; Chimenti S; Soyer HP; Kerl H; Höfler H
    Arch Dermatol Res; 1991; 283(8):500-5. PubMed ID: 1686168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proto-oncogenes in normal and tumor tissues of human skin.
    Ogiso Y; Oikawa T; Kondo N; Kuzumaki N; Sugihara T; Ohura T
    J Invest Dermatol; 1988 Jun; 90(6):841-4. PubMed ID: 2897396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma.
    Husain Z; FitzGerald GB; Wick MM
    J Invest Dermatol; 1990 Nov; 95(5):571-5. PubMed ID: 2121834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
    Carr J; Mackie RM
    Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
    Ohashi A; Funasaka Y; Ueda M; Ichihashi M
    Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P; Itin P; Rufli T
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High BRAF mutation frequency does not characterize all melanocytic tumor types.
    Saldanha G; Purnell D; Fletcher A; Potter L; Gillies A; Pringle JH
    Int J Cancer; 2004 Sep; 111(5):705-10. PubMed ID: 15252839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.
    Orian JM; Vasilopoulos K; Yoshida S; Kaye AH; Chow CW; Gonzales MF
    Br J Cancer; 1992 Jul; 66(1):106-12. PubMed ID: 1322154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.
    Tschandl P; Berghoff AS; Preusser M; Pammer J; Pehamberger H; Kittler H
    Br J Dermatol; 2016 Feb; 174(2):364-70. PubMed ID: 26613644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.
    Platz A; Ringborg U; Grafström E; Höög A; Lagerlöf B
    Melanoma Res; 1995 Apr; 5(2):101-6. PubMed ID: 7620336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases.
    Palmieri G; Ascierto PA; Cossu A; Colombino M; Casula M; Botti G; Lissia A; Tanda F; Castello G
    Melanoma Res; 2003 Apr; 13(2):167-70. PubMed ID: 12690300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression in skin tumors induced in hairless mice by chronic exposure to ultraviolet B irradiation.
    Sato H; Suzuki JS; Tanaka M; Ogiso M; Tohyama C; Kobayashi S
    Photochem Photobiol; 1997 May; 65(5):908-14. PubMed ID: 9155265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
    Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
    J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.
    Nagai MA; Habr-Gama A; Oshima CT; Brentani MM
    Dis Colon Rectum; 1992 May; 35(5):444-51. PubMed ID: 1373678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma antigen-encoding gene expression in melanocytic naevi and cutaneous malignant melanomas.
    Basarab T; Picard JK; Simpson E; Russell-Jones R
    Br J Dermatol; 1999 Jan; 140(1):106-8. PubMed ID: 10215777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.